BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 11140239)

  • 1. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.
    Toupance O; Bouedjoro-Camus MC; Carquin J; Novella JL; Lavaud S; Wynckel A; Jolly D; Chanard J
    Transpl Int; 2000; 13(6):413-9. PubMed ID: 11140239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients.
    Kruger RM; Paranjothi S; Storch GA; Lynch JP; Trulock EP
    J Heart Lung Transplant; 2003 Jul; 22(7):754-63. PubMed ID: 12873543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
    Schachtner T; Stein M; Reinke P
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.
    Pouteil-Noble C; Ecochard R; Bosshard S; Lacavalerie B; Donia A; Landrivon G; Tardy JC; Dubernard JM; Aymard M; Touraine JL
    Transpl Int; 1992; 5 Suppl 1():S26-9. PubMed ID: 14621724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection and graft rejection in renal transplantation.
    Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
    Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
    Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
    Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological responses to cytomegalovirus during renal transplant rejection.
    Sherlock CH; Denegri JF; Ashley RL
    Transplantation; 1991 Aug; 52(2):272-5. PubMed ID: 1651576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
    Felipe C; Ferreira AN; de Paula M; Viana L; Cristelli M; Medina Pestana J; Tedesco-Silva H
    Transpl Infect Dis; 2019 Dec; 21(6):e13106. PubMed ID: 31081566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity.
    Künzle N; Petignat C; Francioli P; Vogel G; Seydoux C; Corpataux JM; Sahli R; Meylan PR
    Transpl Infect Dis; 2000 Sep; 2(3):118-26. PubMed ID: 11429022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytomegalovirus infection, a risk factor for acute graft rejection in renal transplant recipients. A case-controlled study].
    Bouedjoro-Camus MC; Novella JL; Toupance O; Wynckel A; Carquin J; Jolly D; Chanard J
    Presse Med; 1999 Mar; 28(12):619-24. PubMed ID: 10228457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of cytomegalovirus infection after pancreas transplantation.
    Parsaik AK; Bhalla T; Dong M; Rostambeigi N; Dierkhising RA; Dean P; Abraham R; Prieto M; Kremers WK; Razonable RR; Kudva YC
    Transplantation; 2011 Nov; 92(9):1044-50. PubMed ID: 21904269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.